Free Trial

FibroGen (FGEN) SEC Filings & 10K Form

FibroGen logo
$0.48 -0.02 (-3.76%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$0.49 +0.01 (+1.51%)
As of 01/31/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent FibroGen SEC Filings

DateFilerForm TypeView
01/10/2025
5:15 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:16 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:01 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
8:15 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:52 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SC 13G/A
11/12/2024
1:33 PM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
11:11 AM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/03/2024
3:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:10 PM
FibroGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/10/2024
11:15 PM
FibroGen (Filer)
Form EFFECT
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
FibroGen (Subject)
Form SC 13G/A
06/28/2024
4:08 PM
FibroGen (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/26/2024
7:00 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:30 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM
Adib Deyaa (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:37 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:12 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
7:00 PM
Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:46 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
8:55 PM
FibroGen (Filer)
Form ARS
04/24/2024
4:01 PM
FibroGen (Filer)
Form DEF 14A
04/24/2024
4:08 PM
FibroGen (Filer)
Form DEFA14A
04/24/2024
3:15 PM
Adib Deyaa (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2024
4:58 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
6:06 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:17 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
You won’t believe where OpenAI billionaire is investing now (Ad)

Billionaire Sam Altman has become one of the most powerful men in the world by running OpenAI… But there’s a far lesser known investment he’s making that could put OpenAI to shame. In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI… And the US Military… not to mention hundreds of other giant companies around the globe. To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office… Which ordered the government to take this incredible new technology seriously.

03/08/2024
6:18 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:19 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
7:33 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
7:28 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
7:29 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:37 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SC 13G
02/05/2024
7:08 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FGEN) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners